Poseida Therapeutics, Inc. (PSTX) Hits Fresh High: Is There Still Room to Run?

Shares of Poseida Therapeutics, Inc. (PSTX) have been strong performers lately, with the stock up 196% over the past month. The stock hit a new 52-week high of $9.58 in the previous session. Poseida Therapeutics, Inc. has gained 182.7% since the start of the year compared to the -1.7% move for the Zacks Medical sector and the -8.8% return for the Zacks Medical - Biomedical and Genetics industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't misse ...